招募中 NCT06926374

Cornerstone Robotics Sentire手术系统在主要胃肠道及泌尿外科手术中的前瞻性评估

结直肠癌胃癌前列腺癌食管癌膀胱癌/尿路上皮癌肾癌胆道癌不适用

机械人辅助手术已进行超过二十年,具有良好的成功率及安全性。然而,过去只有一种主导的机械人手术系统可供使用,导致机械人手术成本高昂。最近,香港中文大学(CUHK)的研究人员推出了一种新的机械人手术系统(Sentire机械人手术系统)。

适应症:Colorectal Carcinoma、Rectal Prolapse、Prostate Cancer (Adenocarcinoma)、Bladder Cancer、Kidney Cancer、Hiatal Hernia With Gastroesophageal Reflux Disease、GIST - Gastrointestinal Stromal Tumor、Esophageal Cancer、Gallstones、Gastric Cancer

入组条件

纳入标准

  • Body mass index \<35 kg/m2
  • Suitable for the listed minimally invasive surgical procedures for treatment of respective diseases
  • Willingness to participate as demonstrated by giving informed consent
  • \- Adenocarcinoma or large adenoma (not amenable to endoscopic removal) located at the colorectum (from the cecum to the anal verge) amenable to minimally invasive surgery
  • \- Mid/low rectal adenocarcinoma located \<12 cm from the anal verge
  • Clinically diagnosed with previously untreated and uncomplicated rectal prolapse or enterocele
  • \- Clinically diagnosed with nonmetastatic adenocarcinoma of prostate
  • \- Clinically diagnosed with nonmetastatic kidney cancer
  • \- Clinically diagnosed with nonmetastatic bladder cancer
  • Robotic Esophageal Hiatal Surgery and Fundoplication
  • \- Clinically diagnosed with Hiatal Hernia and / or Gastroesophageal reflux disease amendable to fundoplication
  • \- Clinical diagnosis of gastric tumor (Adenocarcinoma or Gastrointestinal Stromal Tumor (GIST)) amendable to minimally invasive radical gastrectomy
  • \- Clinical diagnosis of carcinoma of esophagus amendable to minimally invasive esophagectomy
  • \- Symptomatic gallbladder stones clinically indicated for laparoscopic cholecystectomy

排除标准

  • Contraindication to general anesthesia
  • Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic intervention
  • Untreated active infection
  • Noncorrectable coagulopathy
  • Presence of another malignancy or distant metastasis
  • Emergency surgery
  • Vulnerable population (e.g., mentally disabled, pregnancy)
  • Robotic Colorectal Resection
  • T4 tumor
  • Recurrent tumor
  • Extensive previous abdominal surgery precluding minimally invasive surgery
  • Robotic Transanal Total Mesorectal Excision
  • T4 tumor or involvement of circumferential resection margin even after neoadjuvant therapy
  • Tumor requiring multivisceral resection
  • Tumor requiring abdominoperineal resection; recurrent rectal tumor
  • T1 tumor that can be treated by local excision
  • Extensive previous abdominal surgery
  • Robotic Rectopexy
  • \- Extensive previous abdominal surgery precluding minimally invasive surgery
  • Radical Prostatectomy
  • \- Previous history of prostate surgery (e.g., transurethral resection of prostate)
  • Total or Partial Nephrectomy
  • Previous ipsilateral kidney surgery
  • Complex kidney anatomy (e.g., horseshoe kidney, complex renal vascular anatomy)
  • Radical Cystectomy
  • \- Previous history of laparotomy precluding minimally invasive surgery
  • Robotic Gastrectomy
  • \- Previous history of laparotomy precluding minimally invasive surgery
  • Robotic Esophagectomy
  • \- Esophageal carcinoma after definitive chemoradiotherapy and indicated for salvage esophagectomy

入组条件维持 ClinicalTrials.gov 原始英文登记资料,实际入组资格以研究团队的正式评估与受试者知情同意书为准。资料来源:ClinicalTrials.gov,每两周自动更新,最后同步:2026年10月8日。